FMR LLC 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-12 10:28 am Purchase |
2025-03-31 | 13G | Dianthus Therapeutics, Inc. DNTH |
FMR LLC | 4,482,609 14.000% |
2,264,397 (+102.08%) |
Filing |
| 2023-11-13 09:02 am Purchase |
2023-11-10 | 13G | Dianthus Therapeutics, Inc. DNTH |
FMR LLC | 2,218,212 14.970% |
2,218,212 (New Position) |
Filing |